# Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis

> **NCT00407043** · PHASE4 · COMPLETED · sponsor: **Ophthalmic Consultants of Long Island** · enrollment: 5 (actual)

## Conditions studied

- Dry Eye Disease
- Keratoconjunctivitis Sicca

## Interventions

- **DRUG:** Lotemax
- **DRUG:** Restasis

## Key facts

- **NCT ID:** NCT00407043
- **Lead sponsor:** Ophthalmic Consultants of Long Island
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2011-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407043, "Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00407043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*